Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.
about
Role of Glia in Memory Deficits Following Traumatic Brain Injury: Biomarkers of Glia DysfunctionRole of HIV in amyloid metabolismThe role of inflammasome in Alzheimer's diseaseProtection against Experimental Stroke by Ganglioside GM1 Is Associated with the Inhibition of AutophagyCeramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ AccumulationElevation of 20-carbon long chain bases due to a mutation in serine palmitoyltransferase small subunit b results in neurodegenerationEarly activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampiCholesterol-mediated activation of acid sphingomyelinase disrupts autophagy in the retinal pigment epitheliumCross-talk of membrane lipids and Alzheimer-related proteins.Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.HFE gene variants, iron, and lipids: a novel connection in Alzheimer's diseaseBrain lipidomes of subcortical ischemic vascular dementia and mixed dementiaImaging mass spectrometry detection of gangliosides species in the mouse brain following transient focal cerebral ischemia and long-term recoveryMicroRNA expression profiling reveals miRNA families regulating specific biological pathways in mouse frontal cortex and hippocampusAcid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease.Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disordersDistinctive RNA expression profiles in blood associated with Alzheimer disease after accounting for white matter hyperintensities.Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease.HIV-1 phylogenetic analysis shows HIV-1 transits through the meninges to brain and peripheral tissues.The pathological roles of ganglioside metabolism in Alzheimer's disease: effects of gangliosides on neurogenesis.Increased oxidative stress impairs adipose tissue function in sphingomyelin synthase 1 null mice.Are there roles for brain cell senescence in aging and neurodegenerative disorders?FTY720/fingolimod, a sphingosine analogue, reduces amyloid-β production in neurons.Gadd153 and NF-κB crosstalk regulates 27-hydroxycholesterol-induced increase in BACE1 and β-amyloid production in human neuroblastoma SH-SY5Y cells.RNA-seq analysis of broiler liver transcriptome reveals novel responses to high ambient temperature.Factors affecting longitudinal trajectories of plasma sphingomyelins: the Baltimore Longitudinal Study of Aging.Many ceramides.Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease.Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's diseaseDissociation of ERK signalling inhibition from the anti-amyloidogenic action of synthetic ceramide analoguesComparative lipidomic analysis of mouse and human brain with Alzheimer disease.Computational modeling of sphingolipid metabolism.Sphingolipid and ceramide homeostasis: potential therapeutic targets.Sphingolipid-modulated exosome secretion promotes clearance of amyloid-β by microglia.Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's DiseaseNetwork Analysis of a Comprehensive Knowledge Repository Reveals a Dual Role for Ceramide in Alzheimer's Disease.Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewedAnnotation of the human cerebrospinal fluid lipidome using high resolution mass spectrometry and a dedicated data processing workflow.Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction.Dysfunctional pro-ceramide, ER stress, and insulin/IGF signaling networks with progression of Alzheimer's disease
P2860
Q26766026-4FD42CFA-C521-42C4-A0E4-4261631093D0Q26824179-2DB0D91E-AE79-4FE4-B24E-6DC1540F7863Q26996822-4DEE6B03-02F7-4B9A-8855-E3A5314D3D66Q27336002-A90EED93-72E4-4F90-908D-F199888C6A7AQ28087030-18A7D99C-CED7-4926-AFF9-0410F8CDDDC2Q28512069-FF0ED11F-E185-4586-848C-0DD0A0B6CF70Q28580519-A0C6AB0C-867C-43F6-A2DE-3E1DB493A11FQ30612009-EC24BD99-5256-478F-9629-DA7497B1A1CAQ33592538-F51D8B37-4402-4DC1-B064-A73ECA67935EQ33614523-3E76281F-1C19-49A9-B693-C01F570EAD93Q33861622-D1955E2C-B3A8-4E74-A3DB-CD0753463A8CQ33906496-266A80C8-6566-4432-8E0D-AE90597BD1A7Q33936707-2C361DED-FA18-4C00-99B8-ACD83E8D731BQ33952511-93B50EF5-BFD0-4574-A579-9C10DBA935E5Q33964297-ADF9BD37-E6BC-44AF-9AE2-FFBE834C6C68Q34016222-84729613-2376-4431-AA5E-1AC8C82D2B4CQ34071221-18026B3D-605F-4B64-96B6-DF29846B6994Q34223125-F88C34B3-880C-4447-BE6A-7115D20DDDE1Q34420094-AF8AAB68-9560-446C-8627-E5CD9B7DF4A6Q34512696-DA9CFC99-5C07-4BB1-BDD7-25D7F80FF69DQ34674948-ABAC3D0A-C5E6-4734-8781-60D86B4E59ACQ34688159-051B9F2B-AAC1-4D7E-8E38-C9EA096F3381Q34718530-6A5FA7D5-6FA7-414D-A0F7-E3426D40BF76Q34947624-F24B9607-EC85-4752-BFD8-F1E049EEE642Q34986547-24A6995C-BB57-47AF-ABD5-BA6B22FD579EQ35027653-131CD581-68B2-428D-A860-12FBD69CAE6BQ35149996-B6C51A29-A884-4E6C-9C68-0DF569DBF1C0Q35555867-8AE1FEF7-5EB2-4F36-9D4B-440B7EC41C07Q35566575-9D221EB7-1149-4DC6-AF52-A6E918CF78D6Q35676462-F65D3A96-2143-4744-99B5-113A081019AEQ35710041-D5C4C0A1-D959-4ADC-BAB9-32E83E871ECFQ35746698-D2DC256F-0F32-428E-AD4D-3F6ABE0451F5Q35778875-F89AF7BB-C931-4AB6-B6DE-4A725CE96119Q35879557-28F17358-19DC-419B-9D2E-A832365961B1Q35912013-29A1E13D-F889-4107-A3CA-8C9048B24557Q35915842-07FB35CB-5EED-4EF0-A0C1-8ABE3EB44438Q35997884-844583AD-8E3A-4555-B145-CB3CC77134C7Q35997902-84C69DC0-B424-49D9-9C91-C90401291FD8Q36002934-D1291B33-983C-4123-BAFF-C60EC7597329Q36036789-AD5EE89C-2A86-4B5C-953C-E59900057D82
P2860
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.
@ast
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.
@en
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.
@nl
type
label
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.
@ast
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.
@en
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.
@nl
prefLabel
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.
@ast
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.
@en
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.
@nl
P2093
P2860
P1476
Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.
@en
P2093
Mihyun Bae
Norman J Haughey
Veera V R Bandaru
P2860
P304
P356
10.1016/J.BBALIP.2010.05.003
P407
P50
P577
2010-05-07T00:00:00Z